Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Moreno Tresoldi and Lorenzo Dagna.
Connection Strength

3.804
  1. Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation. Front Immunol. 2021; 12:675678.
    View in: PubMed
    Score: 0.236
  2. Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study. Lancet Rheumatol. 2021 Apr; 3(4):e253-e261.
    View in: PubMed
    Score: 0.232
  3. Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. Microvasc Res. 2021 01; 133:104071.
    View in: PubMed
    Score: 0.226
  4. Colchicine treatment in community healthcare setting to prevent severe COVID-19. Ann Rheum Dis. 2020 Aug 27.
    View in: PubMed
    Score: 0.225
  5. GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study. Lancet Rheumatol. 2020 Aug; 2(8):e465-e473.
    View in: PubMed
    Score: 0.222
  6. Treating COVID-19 with colchicine in community healthcare setting. Clin Immunol. 2020 08; 217:108490.
    View in: PubMed
    Score: 0.221
  7. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol. 2020 Jun; 2(6):e325-e331.
    View in: PubMed
    Score: 0.220
  8. Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency Crit Care Resusc. 2020 04 01; 22(2):91-94.
    View in: PubMed
    Score: 0.219
  9. Myocarditis: An Interleukin-1-Mediated Disease? Front Immunol. 2018; 9:1335.
    View in: PubMed
    Score: 0.193
  10. Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester Disease. Front Immunol. 2018; 9:1233.
    View in: PubMed
    Score: 0.193
  11. C3-glomerulopathy and MGUS: the skin beyond the kidney. QJM. 2018 Mar 01; 111(3):187-188.
    View in: PubMed
    Score: 0.189
  12. Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis. J Neurol Neurosurg Psychiatry. 2018 04; 89(4):441-444.
    View in: PubMed
    Score: 0.182
  13. Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart Failure. Front Immunol. 2017; 8:131.
    View in: PubMed
    Score: 0.176
  14. Testosterone in males with COVID-19: A 7-month cohort study. Andrology. 2022 01; 10(1):34-41.
    View in: PubMed
    Score: 0.060
  15. A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients. J Crit Care. 2021 12; 66:14-19.
    View in: PubMed
    Score: 0.060
  16. Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19. Sci Rep. 2021 May 17; 11(1):10699.
    View in: PubMed
    Score: 0.059
  17. Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19. Clin Microbiol Infect. 2021 08; 27(8):1190-1192.
    View in: PubMed
    Score: 0.059
  18. The Spectrum of COVID-19-Associated Myocarditis: A Patient-Tailored Multidisciplinary Approach. J Clin Med. 2021 May 04; 10(9).
    View in: PubMed
    Score: 0.059
  19. Pulmonary Vascular Thrombosis in COVID-19 Pneumonia. J Cardiothorac Vasc Anesth. 2021 Dec; 35(12):3631-3641.
    View in: PubMed
    Score: 0.058
  20. Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19. Sci Rep. 2020 12 04; 10(1):21291.
    View in: PubMed
    Score: 0.057
  21. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clin Microbiol Infect. 2021 Mar; 27(3):451-457.
    View in: PubMed
    Score: 0.057
  22. Biobanking for COVID-19 research. Panminerva Med. 2020 Oct 19.
    View in: PubMed
    Score: 0.057
  23. Continuous positive airway pressure and pronation outside the intensive care unit in COVID 19 ARDS. Minerva Med. 2020 Sep 30.
    View in: PubMed
    Score: 0.057
  24. Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. Crit Care Resusc. 2020 Sep; 22(3):200-211.
    View in: PubMed
    Score: 0.056
  25. Stranger Months: How SARS-CoV-2, Fear of Contagion, and Lockdown Measures Impacted Attendance and Clinical Activity During February and March 2020 at an Urban Emergency Department in Milan. Disaster Med Public Health Prep. 2021 10; 15(5):e33-e42.
    View in: PubMed
    Score: 0.056
  26. Low prevalence of arrhythmias in clinically stable COVID-19 patients. Pacing Clin Electrophysiol. 2020 08; 43(8):891-893.
    View in: PubMed
    Score: 0.056
  27. Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study. Ann Rheum Dis. 2020 10; 79(10):1277-1285.
    View in: PubMed
    Score: 0.056
  28. Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy. Clin Immunol. 2020 08; 217:108509.
    View in: PubMed
    Score: 0.055
  29. Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study. Eur J Intern Med. 2020 06; 76:43-49.
    View in: PubMed
    Score: 0.055
  30. Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. Crit Care Resusc. 2020 Apr 23.
    View in: PubMed
    Score: 0.055
  31. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Crit Care Resusc. 2020 04 15; 22(2):95-97.
    View in: PubMed
    Score: 0.055
  32. Long-term clinical outcomes of patients with rheumatoid arthritis and concomitant coronary artery disease. Am J Cardiovasc Dis. 2017; 7(1):9-18.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.